MoonLake Immunotherapeutics - MLTX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$1.53B
QoQ value delta ($000)
+$318.1M (+26.25%)
Implied price effect (QoQ)
+4.47%
Shares
Total shares
78,696,483
QoQ shares delta
+13,577,659 (+20.85%)
Total shares held by funds (by quarter)

Market chart (MLTX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 175 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BVF INC/IL 311,544 16,001,284 7.97%
Deep Track Capital, LP 136,271 6,999,025 1.98%
T. Rowe Price Investment Management, Inc. 83,344 4,280,624 0.05%
D. E. Shaw & Co., Inc. 65,526 3,365,507 0.03%
JANUS HENDERSON GROUP PLC 64,303 3,451,628 0.03%
Cormorant Asset Management, LP 62,409 3,205,433 3.2%
Jupiter Topco LLC 60,082 3,085,906 0.02%
Logos Global Management LP 52,082 2,675,000 2.24%
Weiss Asset Management LP 50,267 2,581,813 0.53%
CITADEL ADVISORS LLC 47,853 2,457,793 0.01%
TWO SIGMA INVESTMENTS, LP 33,397 1,715,349 0.02%
MPM BioImpact LLC 31,287 1,606,967 1.91%
JPMORGAN CHASE & CO 27,603 1,386,422 0.0%
Vivo Capital, LLC 27,258 1,400,000 2.49%
JANE STREET GROUP, LLC 22,769 1,169,486 0.0%
Point72 Asset Management, L.P. 22,560 1,158,732 0.02%
BlackRock, Inc. 21,315 1,094,791 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 20,279 1,041,527 0.0%
BALYASNY ASSET MANAGEMENT L.P. 17,770 912,715 0.02%
GREAT POINT PARTNERS LLC 16,662 855,813 3.15%
Candriam S.C.A. 14,972 769,766 0.07%
BANK OF AMERICA CORP /DE/ 14,639 751,897 0.0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 14,617 750,777 0.01%
Trails Edge Capital Partners, LP 14,602 750,000 2.32%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,017 719,942 0.0%